Case sharing of "Clinical Study on Specific Dietary Fiber Nutrition Intervention for Type 2 Diabetes Mellitus".
Patient Information
Name: Xu Moumou
Gender: Male
Age: 47 years old
Home address: Caidian, Huangpi District, Wuhan City, Hubei Province
Hospital: Wuhan Huangpi District Hospital of Traditional Chinese Medicine
Description
In 2008, he was diagnosed with type 2 diabetes mellitus in Huangpi District Hospital of Traditional Chinese Medicine, using hypoglycemic drugs: acarbose, 3 times a day, 50mg/time; Metformin, 1 time daily, 0.5 g/time, insulin: Yaslink 30R, 22 units in the morning, 16 units in the evening.
On November 16, 2016, he participated in the "Clinical Study of Dietary Fiber Intervention for Type 2 Diabetes", and the patient currently has polyuria, body weight loss symptoms, no complications, and hypertension comorbidities.
physical examination
1. Inspection time: November 16, 2016
2. Height: 170cm
3. Weight: 64kg
4、BMI:22.1
Nutritional interventions
Specific prebiotic dietary fiber fortification interventions
(1) Insist on using hypoglycemic drugs according to the doctor's instructions and monitor blood sugar in real time.
(2) Received a specific prebiotic-type dietary fiber nutrition fortification intervention, which was implemented on December 30, 2016.
a. Provided by: Medical Nutrition Research Center, Tsinghua Strait Research Institute;
b. Dosage and method: Take 2 times a day, 10 grams each time, and take it with warm water before meals;
c. Take-period: 12 weeks.
(3) Ensure a balanced diet and adequate water intake every day.
Analysis of results
Comparison of biochemical index results
Check the items | Day 0 | 1 month later | After 4 months |
Glycosylated hemoglobin (%) | 9.9 | 9.3 | 5.3 |
Fasting blood glucose (mmol/L) | 16.52 | 12.72 | 6.89 |
餐后2h血糖(mmol/L) | 23.2 | 24.2 | 9.0 |
Total cholesterol (mmol/L) | 4.45 | 5.21 | 3.77 |
Triglycerides (mmol/L) | 0.81 | 1.11 | 1.56 |
低密度脂蛋白(mmol/L) | 2.85 | 2.68 | 1.58 |
高密度脂蛋白(mmol/L) | 0.99 | 1.40 | 1.09 |
The patient's glycosylated hemoglobin, fasting blood glucose and 2-hour postprandial blood glucose indexes were all high at the time of enrollment examination, and high-density lipoprotein was low in the four blood lipid tests, indicating that the patient's blood glucose control was poor. After 3 months of specific prebiotic nutritional intervention, all blood glucose indexes were significantly improved, glycosylated hemoglobin, fasting blood glucose and postprandial blood glucose were controlled within the ideal range. The lipid profile is also within the normal range, so it is recommended that patients continue to take specific prebiotics to help patients better control blood sugar and blood lipids.
Clinical findings are as follows:
When you first enrolled
After a one-month observation period
After 3 months of taking specific prebiotics